Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1980 Sep;56(659):671. doi: 10.1136/pgmj.56.659.671

Jaundice following warfarin therapy.

D B Jones, M C Makepeace, P M Smith
PMCID: PMC2425941  PMID: 7465480

Abstract

A case of intrahepatic cholestatic jaundice following warfarin therapy is described. The patient made a complete recovery on withdrawal on the drug.

Full text

PDF

Page 671

671

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eliastam M., Holmes A. W. Hepatitis, arthritis and lupus cell phenomena caused by methyldopa. Am J Dig Dis. 1971 Nov;16(11):1014–1018. doi: 10.1007/BF02235014. [DOI] [PubMed] [Google Scholar]
  2. Hargreaves T., Howell M. PHENINDIONE JAUNDICE. Br Heart J. 1965 Nov;27(6):932–936. doi: 10.1136/hrt.27.6.932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. PORTAL R. W., EMANUEL R. W. Phenindione hepatitis complicating anticoagulant therapy. Br Med J. 1961 Nov 18;2(5263):1318–1319. doi: 10.1136/bmj.2.5263.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Rehnqvist N. Intrahepatic jaundice due to warfarin therapy. Acta Med Scand. 1978;204(4):335–336. doi: 10.1111/j.0954-6820.1978.tb08449.x. [DOI] [PubMed] [Google Scholar]
  5. Toghill P. J., Smith P. G., Benton P., Brown R. C., Matthews H. L. Methyldopa liver damage. Br Med J. 1974 Aug 31;3(5930):545–548. doi: 10.1136/bmj.3.5930.545. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES